Literature DB >> 18785105

[Prevention and treatment of somatic complications arising from the use of antipsychotics].

W Cahn1, D Ramlal, R Bruggeman, L de Haan, F E Scheepers, M M van Soest, J Assies, C J Slooff.   

Abstract

BACKGROUND: Antipsychotics are effective drugs that are prescribed frequently for a large group of patients. However, they also have many side-effects which can lead ultimately to serious somatic complications. These complications fall into various categories: metabolic, cardiovascular, neurobiological, haematological, gastro-intestinal and urogenital. AIM: To make an inventory of the side-effects and advise on ways of monitoring and preventing them. method The multidisciplinary working group on somatic complications arising from the use of antipsychotics (Werkgroep Somatische Complicaties) has collected literature on the subject and has discussed it at a number of consensus meetings. results The most frequent somatic complications are described on the basis of specific risk profiles and advice is given on how to identify these complications and on how to treat them when necessary. It is essential to monitor, systematically and regularly, somatic complications arising from the use of antipsychotics; furthermore, polypharmacy should be avoided. The person ultimately responsible for this is the doctor who has prescribed the antipsychotics. In addition, it is important to draw patients' attention to the general rules for a healthy lifestyle: no smoking, a balanced diet and adequate exercise.
CONCLUSION: It is very important that somatic complications should be monitored carefully and accurately. So far, the Netherlands has no official guidelines on ways to identify and treat somatic complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18785105

Source DB:  PubMed          Journal:  Tijdschr Psychiatr        ISSN: 0303-7339


  7 in total

1.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

2.  Some side effects and effcts on physical activity of second-generation antipsychotics: A study in children and adolescents.

Authors:  Soroor Arman; Tahere Sadeghye; Reza Bidaki
Journal:  Adv Biomed Res       Date:  2014-11-29

Review 3.  Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis.

Authors:  Ayala Shirazi; Brendon Stubbs; Lucia Gomez; Susan Moore; Fiona Gaughran; Robert J Flanagan; James H MacCabe; John Lally
Journal:  Int J Mol Sci       Date:  2016-06-02       Impact factor: 5.923

4.  A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012.

Authors:  Luuk J Kalverdijk; Christian J Bachmann; Lise Aagaard; Mehmet Burcu; Gerd Glaeske; Falk Hoffmann; Irene Petersen; Catharina C M Schuiling-Veninga; Linda P Wijlaars; Julie M Zito
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2017-10-11       Impact factor: 3.033

5.  Support staff's perceptions of discontinuing antipsychotics in people with intellectual disabilities in residential care: A mixed-method study.

Authors:  Bas Kleijwegt; Addy Pruijssers; Lydie de Jong-Bakker; Koos de Haan; Harmieke van Os-Medendorp; Berno van Meijel
Journal:  J Appl Res Intellect Disabil       Date:  2019-02-20

6.  Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review.

Authors:  Mariken Dinnissen; Andrea Dietrich; Judith H van der Molen; Anne M Verhallen; Ynske Buiteveld; Suzanne Jongejan; Pieter W Troost; Jan K Buitelaar; Barbara J van den Hoofdakker; Pieter J Hoekstra
Journal:  J Clin Psychopharmacol       Date:  2021 Jan/Feb 01       Impact factor: 3.118

7.  Somatic Care with a Psychotic Disorder. Lower Somatic Health Care Utilization of Patients with a Psychotic Disorder Compared to Other Patient Groups and to Controls Without a Psychiatric Diagnosis.

Authors:  Wilma Swildens; Fabian Termorshuizen; Alex de Ridder; Hugo Smeets; Iris M Engelhard
Journal:  Adm Policy Ment Health       Date:  2016-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.